Literature DB >> 30991854

HDAC inhibitors in liver cancer: which route to take?

Tobias Kiesslich1,2, Daniel Neureiter3,4.   

Abstract

Entities:  

Keywords:  Hepatocellular carcinoma; drug combination; epigenetics; histone acetylation; histone deacetylase inhibitor

Year:  2019        PMID: 30991854     DOI: 10.1080/17474124.2019.1605289

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


× No keyword cloud information.
  1 in total

1.  Can We Efficiently Target HDAC in Cancer?

Authors:  Tobias Kiesslich; Daniel Neureiter
Journal:  Cancers (Basel)       Date:  2022-08-22       Impact factor: 6.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.